Description
WHOLE BLOOD BANK&BLOOD RELATED PRODUCTS
First action · last action
2019-02-26 · 2020-02-21
Transactions
3
First transaction's obligation
$695,176
Base + all options value (sum of deltas)
$764,031
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-02-26+$695,176= $695,176
- Mod P000012019-09-25+$119,838= $815,013
- Mod P000022020-02-21-$50,982= $764,031
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-02-26 | +$695,176 | $695,176 | WHOLE BLOOD BANK&BLOOD RELATED PRODUCTS |
| Mod P00001· FUNDING ONLY ACTION | 2019-09-25 | +$119,838 | $815,013 | WHOLE BLOOD BANK&BLOOD RELATED PRODUCTS |
| Mod P00002· CLOSE OUT | 2020-02-21 | −$50,982 | $764,031 | WHOLE BLOOD BANK&BLOOD RELATED PRODUCTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI SX3XGHRJMNQ5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24826N0419 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $792,973 | FY2026 |
| 36C24826N0399 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6506 · BLOOD AND BLOOD PRODUCTS | $354,763 | FY2026 |
| 36C24826N0424 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $268,659 | FY2026 |
| 36C24826N0400 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $314,881 | FY2026 |
| 36C24826N0347 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $619,287 | FY2026 |
| 36C24826D0015 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6640 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24826A0029 | ABBOTT LABORATORIES INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $0 | FY2026 |
| 36C24826N0821 | ABBOTT LABORATORIES INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $289,849 | FY2026 |
| 36C24826P1068 | CEPHEID | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $63,150 | FY2026 |
| 36C24826P1104 | HOLOGIC SALES AND SERVICE, LLC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $263,800 | FY2026 |
| 36C24826P1126 | TRILLAMED LLC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $25,838 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24819P0793_3600_-NONE-_-NONE- · retrieved 2026-09-26.